Sign In
Buy HTBX
$2.38
+0 (+0%)
At Close: Aug 17, 2022
Heat Biologics' Lead Candidate Shows Overall Survival Benefit In Lung Cancer Study
10:06am, Thursday, 20'th May 2021
Heat Biologics Inc (NASDAQ: HTBX) has reported interim data from the Phase 1/2 trial evaluating its lead product, HS-110, in combination with Bristol-Myers Squibb Co's (NYSE: BMY) Opdivo (nivo
DURHAM, N.C., May 20, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune sys
Heat Biologics Announces Multiple Presentations on PTX-35 at the Upcoming 3rd Annual Treg Directed Therapies Summit
07:30am, Wednesday, 19'th May 2021
DURHAM, N.C., May 19, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune sys
Heat Biologics Appoints Anthony Manning, Ph.D. as Chief Scientific Advisor
07:30am, Monday, 10'th May 2021
DURHAM, N.C., May 10, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune s
Heat Biologics Provides First Quarter 2021 Business Update; Reports Continued Progress on Oncology and COVID-19 Vaccine Programs
07:30am, Wednesday, 05'th May 2021
DURHAM, N.C., May 05, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate t
NSPR Stock: What You Should Know About InspireMD Today
08:40am, Tuesday, 27'th Apr 2021
InspireMD has vastly reduced the number of its shares trading ahead of a likely move to a Nasdaq listed. Conversion of NSPR stock warrants and preferred shares will be more difficult now.
DURHAM, NC / ACCESSWIRE / April 12, 2021 / Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system,
Heat Biologics Provides Year-End Business Update
09:00am, Thursday, 25'th Mar 2021
DURHAM, NC / ACCESSWIRE / March 25, 2021 / Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system,
Heat Biologics to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
07:30am, Monday, 08'th Mar 2021
DURHAM, NC / ACCESSWIRE / March 8, 2021 / Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, i
HTBX Stock: Why Shares of Heat Biologics Are Blazing Higher Today
10:46am, Wednesday, 03'rd Mar 2021
Heat Biologics (HTBX) stock is heating up on Wednesday following new coverage from Cantor Fitzgerald analyst Kristen Kluska. The post HTBX Stock: Why Shares of Heat Biologics Are Blazing Higher Today
HTBX Stock Price Increases Over 25% Pre-Market: Why It Happened
05:46am, Wednesday, 03'rd Mar 2021
The stock price of Heat Biologics, Inc. (Nasdaq: HTBX) has increased by over 25% pre-market. This is why it happened.
Heat Biologics Catapults After Drug Regimen Boosts Lung-Cancer Survival
11:59am, Tuesday, 09'th Feb 2021
Heat Biologics said Tuesday adding its experimental drug to Bristol Myers Squibb's Opdivo helped more lung-cancer patients survive. In response, HTBX stock catapulted.
HTBX Stock Price Increased 103.1% In Day High: Why It Happened
11:40am, Tuesday, 09'th Feb 2021
The stock price of Heat Biologics Inc (NASDAQ:HTBX) increased by over 103.1% in its day high. This is why it happened.
Heat Biologics stock more than doubles after 'positive' trial data of its lung cancer treatment
09:22am, Tuesday, 09'th Feb 2021
Shares of Heat Biologics Inc. more than doubled in very active trading Tuesday, after the biopharmaceutical company focused on modulating the immune system reported "positive" interim data from a Phas
Heat Biologics Cell Therapy Shows Survival Benefit In Mid-Stage Lung Cancer Study, Shares Rally
08:23am, Tuesday, 09'th Feb 2021
Heat Biologics Inc (NASDAQ: HTBX) soars in premarket on the heels of encouraging interim data from the Phase 2 trial evaluating HS-110, in combination with Bristol-Myers Squibb's (NYSE: BMY) Opd
